The effect of Probiotics on preventing patients with breast cancer from cancer-related cognitive impairmentand and its mechanism

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-INQ-17014181

Enrollment

Unknown

Registered

2017-12-27

Start date

2018-01-01

Completion date

Unknown

Last updated

2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer-related cognitive impairmentand

Interventions

probiotics group:probiotics

control group:none

Eligibility

Sex/Gender

Female

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed breast cancer patients (about 500 cases); 2. Aged 20-60 years; 3. Willing and able to cooperate with the experimenter.

Exclusion criteria

Exclusion criteria: 1. The history of brain injury, cerebral hemorrhage, stroke, brain tumor, cerebral infarction, etc. 2. Patients with coronary heart disease, heart attack and cardiac function; 3. Patients with severe liver and kidney disease; 4. Patients with advanced disease or with other malignant tumors; 5. Family history of mental illness or mental illness; 6. Patients with PD and AD or already had cognitive impairment; 7. Alcoholic or drug addicts; 8. Refused entry and unable to cooperate with the healer.

Design outcomes

Primary

Measure	Time frame
cognitive;	—

Countries

China

Contacts

Public ContactTong Jianbin

Xiangya Medical College, Cental South University

498836726@qq.com+86 15386429820

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 20, 2026